2.1100
+0.1800
+(9.33%)
At close: January 10 at 4:00:02 PM EST
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Operating Cash Flow
-27,870.0000
-19,808.0000
-24,865.0000
-23,754.0000
-20,476.0000
Investing Cash Flow
-96.0000
16,196.0000
26,459.0000
-35,917.0000
6,411.0000
Financing Cash Flow
33,611.0000
15,794.0000
--
55,657.0000
15,800.0000
End Cash Position
17,739.0000
17,338.0000
5,219.0000
3,625.0000
7,639.0000
Capital Expenditure
--
--
--
-157.0000
-5.0000
Issuance of Capital Stock
--
--
--
55,583.0000
15,413.0000
Issuance of Debt
--
--
--
--
387.0000
Free Cash Flow
-27,870.0000
-19,808.0000
-24,865.0000
-23,911.0000
-20,481.0000
12/31/2020 - 6/29/2017
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
ACTU Actuate Therapeutics, Inc. Common stock
8.30
+3.75%
INAB IN8bio, Inc.
0.3233
+3.42%
RLMD Relmada Therapeutics, Inc.
0.4124
-8.76%
AIM AIM ImmunoTech Inc.
0.2150
-0.92%
CUE Cue Biopharma, Inc.
1.5100
+4.14%
APTO Aptose Biosciences Inc.
0.2200
+3.19%
COYA Coya Therapeutics, Inc.
5.77
-4.94%
OVID Ovid Therapeutics Inc.
0.8207
-9.80%
AKTX Akari Therapeutics, Plc
1.2150
-5.08%
IMMP Immutep Limited
2.0100
+0.50%